02026nas a2200337 4500000000100000008004100001260001700042653001500059653001000074653002500084653002200109653003000131653001100161653001100172653001200183653000900195653001600204653002400220653001800244100002000262700001300282700001600295700001600311700001500327245005100342300001000393490000700403050002100410520124300431022001401674 2006 d c2006 Jul-Aug10aAdolescent10aAdult10aCase-Control Studies10aElectrophysiology10aEvoked Potentials, Visual10aFemale10aHumans10aleprosy10aMale10aMiddle Aged10aProspective Studies10aReaction Time1 aAndrade Neto JL1 aCunha AP1 aBarreto RBP1 aArantes TEF1 aSantos LPF00a[Visual evoked potential in leprosy patients]. a575-80 v69 aANDRADENETO 20063 a
PURPOSE: To verify the possible alterations in visual evoked potential of leprosy patients.
METHODS: Visual evoked potential examinations were performed in 13 Hansen disease patients, 5 of them with the multibacillary form and 8 with the paucibacillary. This was done at the moment of the diagnosis. The control group enrolled 15 health individuals, without Hansen disease.
RESULTS: The measurement result varied from 102.0 to 120.5 ms, with a mean of 110.1+/-5.7 ms. In the multibacillary form, the values varied from 109.0 to 120.0 ms, mean 111.1+/-5.4. In the paucibacillary, the values varied from 102.0 to 120.5 ms, with a mean of 109.5+/-6.1 ms. The latency values were significantly greater in Hansen disease patients (p<0.0001), even if multibacillary and paucibacillary forms were compared separately. However, there was no significant difference when the pauci- and multibacillary groups were compared.
CONCLUSION: The latency values were significantly greater in leprosy patients. A recommendation can be made for these patients, which is to be submitted to early visual evoked potential as a rule in order to investigate ocular complications, as well as to prevent damages.
a0004-2749